Intentar ORO - Gratis
Rethinking pharma field force efficiency in developing countries
Express Pharma
|July 2025
In developing markets like India, where medical representatives remain the cornerstone of pharma sales, field force inefficiency is an expensive blind spot. Mayuresh Satpute, Partner at Vector Consulting Group, outlines how a shift from rigid Monthly Tour Plans to dynamic Flexible Journey Plans can unlock significant gains in coverage, compliance, and market share
The global pharma industry thrives on high profit margins, allowing companies to invest heavily in product promotion among healthcare professionals to generate sales. In developing markets, this effort is led by a vast network of Medical Representatives (MRS) who engage directly with doctors to drive prescriptions. In India alone, over 600,000 MRs operate nationwide, with top firms employing over 10,000 MRs each.
Pharma companies often rely on such a large sales force, expecting better doctor coverage, greater brand visibility, and increased sales. While this approach can yield initial gains, its impact diminishes over time as inefficiencies emerge. Sales teams typically operate at only 60-70 per cent efficiency due to poor planning and limited engagement with high-priority doctors. Visit frequency compliance is as low as 30-40 per cent, resulting in suboptimal doctor coverage and weakening the effectiveness of the manpower investment.
To address this, firms invest in digital solutions like CRM systems, automated reporting, and performance monitoring. However, these tools often fail to deliver their core objective: timely, productive, and targeted doctor interactions across regions. With lost sales reaching significant levels, firms are compelled to keep investing in their field force, finding themselves in a dilemma, whether to expand the sales force or run digital initiatives to improve efficiency.
This article examines how pharma companies can improve their field force's potential by addressing operational inefficiencies.
Key hurdles in the pharma field force productivity Esta historia es de la edición July 2025 de Express Pharma.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Listen
Translate
Change font size
